Glia · 2004 · 126 citations · 19 references
MedicineNeurosciencePharmacologyNeurochemistryNeurodegenerationNeuropharmacologyMicroglia BiologyNeurodegenerative DiseasesNeuroinflammationNeuroprotectionNeuroprotective PharmacologyReactive GliosisAmyloid ToxicityAmyloid-associated NeurotoxicityAmyloid-beta Induced ApoptosisAmyloid-beta-induced NeurotoxicityGlial-mediated NeurotoxicityGranule Cell LayerNeuronal DysfunctionNeuroprotective Agents
Minocycline, a second-generation tetracycline compound, has been examined as a neuroprotectant in beta-amyloid (A beta)-injected rat hippocampus. At 7 days post-injection, A beta(1-42) caused a significant loss of granule cell layer neurons (28% reduction) compared to control uninjected hippocampus. Hippocampal injection of A beta peptide also led to marked gliosis with numbers of microglia (increased by 26-fold) and immunoreactivity of astrocytes (increased by 11-fold) relative to control, as determined from immunohistochemical analysis. Intraperitoneal administration of minocycline significantly reduced neuronal loss induced by A beta(1-42) (by 80%) and also diminished numbers of microglia (by 69%) and astrocytes (by 36%) relative to peptide alone. Peptide injection increased expression of cyclooxygenase-2 (COX-2) in most (about 70%) of granule cells, a subset (about 20%) of microglia, but not in astrocytes; in the presence of minocycline, COX-2 immunostaining was abolished in microglia. The results from this study suggest that minocycline may have efficacy in the treatment of AD.
19
Risk of Alzheimer's disease and duration of NSAID use
Walter F. Stewart, Claudia H. Kawas, María M. Corrada et al. · Neurology · 1997 · 1.1K citations · Full text
In-vivo measurement of activated microglia in dementia
Annachiara Cagnin, David J. Brooks, Angus Kennedy et al. · The Lancet · 2001 · 1.1K citations
Medicine, Neurology, Neuroscience +14
Juha Yrjänheikki, Tiina Tikka, Riitta Keinänen et al. · Proceedings of the National Academy of Sciences · 1999 · 1K citations